#United States #Geneva #Spineart #SCARLET AC-Ti #anterior cervical cage

Spineart's New SCARLET® AC-Ti Anterior Cervical Cage

Spineart, a leader in spinal surgery innovation, recently announced the full-market launch of its revolutionary SCARLET® AC-Ti secured anterior cervical cage in the United States. This significant step follows the product's successful 510(k) clearance received in May 2024, allowing for extensive clinical evaluations that have bolstered the device’s safety and efficacy credentials.

The SCARLET® AC-Ti anterior cervical cage has been designed with a focus on both functionality and patient safety. According to Dr. Zakhria Belasher, a consultant and spinal surgeon at Insight Surgical Hospital, the cage has demonstrated "consistent performance and reliable standalone stability," highlighting its effectiveness by noting a complete absence of postoperative dysphagia among patients treated with this device. This is particularly notable, as complications following cervical spine surgeries can be significant.

Innovative Design and Technology

One of the standout features of the SCARLET® AC-Ti is its utilization of Ti-LIFE technology, which employs a proprietary additive manufacturing process. This technology is integral in providing a porous structure that closely mimics the properties of human trabecular bone, enabling better biological integration and fusion outcomes.

Spineart’s Chief Commercial Officer, Alessia Erlingher, expressed enthusiasm about the product’s launch, stating, "With SCARLET® AC-Ti, we are introducing an exciting advancement to the ACDF (anterior cervical discectomy and fusion) segment, reinforcing our ongoing commitment to innovation." This statement underscores Spineart’s ambition to provide surgeons with state-of-the-art solutions that can lead to better patient outcomes.

Moreover, the SCARLET® AC-Ti cage boasts a redefined anatomical shape. It incorporates integrated screw guides and an anti-backout mechanism designed to further enhance the security and ease of installation during surgical procedures. These features make it an appealing option for surgical teams aiming to streamline their operational efficiency and improve the overall experience for patients.

Commitment to Surgeon Support and Education

To ensure that the SCARLET® AC-Ti can be effectively integrated into surgical practices, Spineart is committed to providing ongoing support and education for surgeons. Interested medical professionals can reach out to local sales representatives to learn more or gain additional resources to better understand how to utilize this innovation in their practices.

About Spineart

Spineart continues to redefine the landscape of spine surgery with a commitment to quality, innovation, and simplicity. Recognized for its contributions to technological advancements in spinal medical devices, the company was awarded the "Prix de l'Economie Genevoise 2022" for its impact on job creation, commercial activity, and adherence to ESG principles. Their aim is to innovate not just for the sake of advancement but with the ultimate goal of improving patient care worldwide.

For more details on SCARLET® AC-Ti or to explore other offerings from Spineart, please visit Spineart’s official website and follow them on LinkedIn for updates on their latest innovations.

This launch marks an important chapter for Spineart as it accelerates its growth and solidifies its reputation in the global healthcare market, continuing to push the boundaries of what's possible in spinal surgery.